Perspectives in biological monitoring of inhaled nanosized particles

Annals of Occupational Hygiene

Volumn 59, Issue 6, 2015, Pages 669-680

  Rinaldo, Mickael ^a,b,c   Andujar, Pascal ^d,e,f   Lacourt, Aude ^b,c   Martinon, Laurent ^g   Raffin, Mireille Canal ^a,b,c   Dumortier, Pascal ^h   Pairon, Jean Claude ^d,e,f,g   Brochard, Patrick ^a,b,c,g  

^a BORDEAUX UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c INSERM   (France)

^d INSERM U955   (France)

^e FACULTÉ DE MÉDECINE   (France)

^f CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

^g Laboratoire D'étude des Particules Inhalées de la Ville de Paris ^*  (France)

^h ERASME HOSPITAL   (Belgium)

Author keywords

Biological monitoring; Nanoparticles; Quantification of exposure; Translocation; Ultrafine particles

Indexed keywords

NANOPARTICLES; OCCUPATIONAL DISEASES;

BIOLOGICAL MONITORING; ENVIRONMENTAL EXPOSURE; MANUFACTURED NANOPARTICLES; QUANTIFICATION OF EXPOSURE; RETROSPECTIVE EVALUATIONS; STANDARDIZED PROCEDURE; TRANSLOCATION; ULTRAFINE PARTICLE;

SYNTHESIS (CHEMICAL);

NANOPARTICLE;

ANALYSIS; ENVIRONMENTAL MONITORING; EXPOSURE; HUMAN; OCCUPATIONAL EXPOSURE; WORKPLACE;

ENVIRONMENTAL MONITORING; HUMANS; INHALATION EXPOSURE; NANOPARTICLES; OCCUPATIONAL EXPOSURE; WORKPLACE;

EID: 84941570339     PISSN: 00034878     EISSN: 14753162     Source Type: Journal    
DOI: 10.1093/annhyg/mev015     Document Type: Review

References (87)

1. Al Faraj A, Cieslar K, Lacroix G et al. (2009) In vivo imaging of carbon nanotube biodistribution using magnetic resonanceimaging. Nano Lett; 9:1023-7.
2. Amarie S, Zaslansky P, Kajihara Y et al. (2012) Nano-FTIR chemical mapping of minerals in biological materials. Beilstein J Nanotechnol; 3: 312-23.
3. Andujar P, Lanone S, Brochard P et al. (2011) Respiratory effects of manufactured nanoparticles. Rev Mal Respir; 28: e66-75.
4. Arvizo R, Bhattacharya R, Mukherjee P. (2010) Gold nanoparticles: opportunities and challenges in nanomedicine. Expert Opin Drug Deliv; 7: 753-63.
5. Auerbach O, Conston AS, Garfinkel L et al. (1980) Presence of asbestos bodies in organs other than the lung. Chest; 77: 133-7.
6. Baek M, Chung HE, Yu J et al. (2012) Pharmacokinetics, tissue distribution, and excretion of zinc oxide nanoparticles. Int J Nanomedicine; 7: 3081-97.
7. Bakand S, Hayes A, Dechsakulthorn F. (2012) Nanoparticles: a review of particle toxicology following inhalation exposure. Inhal Toxicol; 24: 125-35.
8. Boyes WK, Chen R, Chen C et al. (2012) The neurotoxic potential of engineered nanomaterials. Neurotoxicology; 33: 902-10.
9. Brauer M, Avila-Casado C, Fortoul TI et al. (2001) Air pollution and retained particles in the lung. Environ Health Perspect; 109: 1039-43.
10. Broday DM, Rosenzweig R. (2011) Deposition of fractal-like soot aggregates in the human respiratory tract. Journal of Aerosol Science; 42: 372-86.
11. Brown JS, Wilson WE, Grant LD. (2005) Dosimetric comparisons of particle deposition and retention in rats and humans. Inhal Toxicol; 17: 355-85.
12. Brown JS, Zeman KL, Bennett WD. (2002) Ultrafine particle deposition and clearance in the healthy and obstructed lung. Am J Respir Crit Care Med; 166: 1240-7.
13. Bunn HJ, Dinsdale D, Smith T et al. (2001) Ultrafine particles in alveolar macrophages from normal children. Thorax; 56: 932-4.
14. Card JW, Zeldin DC, Bonner JC et al. (2008) Pulmonary applications and toxicity of engineered nanoparticles. Am J Physiol Lung Cell Mol Physiol; 295: L400-11.
15. Carvalho TC, Peters JI, Williams RO III. (2011) Influence of particle size on regional lung deposition-what evidence is there? Int J Pharm; 406: 1-10.
16. Cheng TH, Ko FC, Chang JL et al. (2012) Bronchiolitis obliterans organizing pneumonia due to titanium nanoparticles in paint. Ann Thorac Surg; 93: 666-9.
17. Choi HS, Ashitate Y, Lee JH et al. (2010) Rapid translocation of nanoparticlesfrom the lung airspaces to the body. Nat Biotechnol; 28: 1300-3.
18. Choi HS, Liu W, Misra P et al. (2007) Renal clearance of quantum dots. Nat Biotechnol; 25: 1165-70.
19. Churg A, Brauer M. (1997) Human lung parenchyma retains PM2.5. Am J Respir Crit Care Med; 155: 2109-11.
20. Churg A, Brauer M. (2000) Ambient atmospheric particles in the airways of human lungs. Ultrastruct Pathol; 24: 353-61.
21. De Jong WH, Hagens WI, Krystek P et al. (2008) Particle sizedependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials; 29: 1912-9.
22. Deering CE, Tadjiki S, Assemi S et al. (2008) A novel method to detect unlabeled inorganic nanoparticles and submicron particles in tissue by sedimentation field-flow fractionation. Part Fibre Toxicol; 5: 18.
23. Deng X, Jia G, Wang H et al. (2007) Translocation and fate of multi-walled carbon nanotubes in vivo. Carbon; 45: 1419-24.
24. Donaldson K, Murphy FA, Duffin R et al. (2010) Asbestos, carbon nanotubes and the pleural mesothelium: a review of the hypothesis regarding the role of long fibre retention in the parietal pleura, inflammation and mesothelioma. Part Fibre Toxicol; 7: 5.
25. Donaldson K, Oberdörster G, Ichihara G et al. (2009) Nanoparticles - one word: a multiplicity of different hazards. Nanotoxicology; 3: 263-64.
26. Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A et al. (2012) Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol; 32: 920-8.
27. Elder A, Gelein R, Silva V et al. (2006) Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect; 114: 1172-8.
28. Erratum in: (2006) Environ Health Perspect; 114(8):1178.
29. Fröhlich E, Roblegg E. (2012) Models for oral uptake of nanoparticles in consumer products. Toxicology; 291: 10-7.
30. Garnett MC, Kallinteri P. (2006) Nanomedicines and nanotoxicology: some physiological principles. Occup Med (Lond); 56: 307-11.
31. Gatti AM, Bosco P, Rivasi F et al. (2011) Heavy metals nanoparticles in fetal kidney and liver tissues. Front Biosci (Elite Ed); 3: 221-6.
32. Gatti AM, Montanari S, Monari E et al. (2004) Detection of micro-and nano-sized biocompatible particles in the blood. J Mater Sci Mater Med; 15: 469-72.
33. Geiser M, Kreyling WG. (2010) Deposition and biokinetics of inhaled nanoparticles. Part Fibre Toxicol; 7: 2.
34. Gray EP, Coleman JG, Bednar AJ et al. (2013) Extraction and analysis of silver and gold nanoparticles from biological tissues using single particle inductively coupled plasma mass spectrometry. Environ Sci Technol; 47: 14315-23.
35. Hagens WI, Oomen AG, de Jong WH et al. (2007) What do we (need to) know about the kinetic properties of nanoparticles in the body? Regul Toxicol Pharmacol; 49: 217-29.
36. Haque AK, Vrazel DM, Uchida T. (1998) Assessment of asbestos burden in the placenta and tissue digests of stillborn infants in South Texas. Arch Environ Contam Toxicol; 35: 532-8.
37. Hauser R, Godleski JJ, Hatch V et al. (2001) Ultrafine particles in human lung macrophages. Arch Environ Health; 56: 150-6.
38. Hull MJ, Abraham JL. (2002) Aluminum welding fumeinduced pneumoconiosis. Hum Pathol; 33: 819-25.
39. Hunt A, Abraham JL, Judson B et al. (2003) Toxicologic and epidemiologic clues from the characterization of the 1952 London smog fine particulate matter in archival autopsy lung tissues. Environ Health Perspect; 111: 1209-14.
40. ISO. (2011) ISO/TS 80004-4:2011. Nanotechnologies - Vocabulary - Part 4: Nanostructured materials. CH1214 Vernier, Genève Suisse: ISO.
41. Journeay WS, Goldman RH. (2014) Occupational handling of nickel nanoparticles: a case report. Am J Ind Med; 57: 1073-6.
42. Kalappanavar NK, Vinodkumar CS, Gouli C et al. (2012) Carbon particles in airway macrophage as a surrogate marker in the early detection of lung diseases. Int J Occup Environ Med; 3: 68-75.
43. Kendall M, Holgate S. (2012) Health impact and toxicological effects of nanomaterials in the lung. Respirology; 17: 743-58.
44. Kettiger H, Schipanski A, Wick P et al. (2013) Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomedicine; 8: 3255-69.
45. Khatri M, Bello D, Gaines P et al. (2013) Nanoparticles from photocopiers induce oxidative stress and upper respiratory tract inflammation in healthy volunteers. Nanotoxicology; 7: 1014-27.
46. Khlebtsov N, Dykman L. (2011) Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies. Chem Soc Rev; 40: 1647-71.
47. Koelmel J, Leland T, Wang H et al. (2013) Investigation of gold nanoparticles uptake and their tissue level distribution in rice plants by laser ablation-inductively coupled-mass spectrometry. Environ Pollut; 174: 222-8.
48. Kreyling WG, Semmler-Behnke M, Möller W. (2006) Ultrafine particle-lung interactions: does size matter? J Aerosol Med; 19: 74-83.
49. Kreyling WG, Semmler-Behnke M, Takenaka S et al. (2013) Differences in the biokinetics of inhaled nano-versus micrometer-sized particles. Acc Chem Res; 46: 714-22.
50. Kulkarni N, Pierse N, Rushton L et al. (2006) Carbon in airway macrophages and lung function in children. N Engl J Med; 355: 21-30.
51. Kunzmann A, Andersson B, Thurnherr T et al. (2011) Toxicology of engineered nanomaterials: focus on biocompatibility, biodistribution and biodegradation. Biochim Biophys Acta; 1810: 361-73.
52. Laborda F, Bolea E, Jiménez-Lamana J. (2014) Single Particle Inductively Coupled Plasma Mass Spectrometry: a powerful tool for nanoanalysis. Anal Chem; 86: 2270-78
53. Landsiedel R, Fabian E, Ma-Hock L et al. (2012) Toxico-/ biokinetics of nanomaterials. Arch Toxicol; 86: 1021-60.
54. Lee CM, Jeong HJ, Yun KN et al. (2012) Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure. Int J Nanomedicine; 7: 3203-9.
55. LeFevre ME, Green FH, Joel DD et al. (1982) Frequency of black pigment in livers and spleens of coal workers: correlation with pulmonary pathology and occupational information. Hum Pathol; 13: 1121-6.
56. Li SD, Huang L. (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm; 5: 496-504.
57. Mills NL, Amin N, Robinson SD et al. (2006) Do inhaled carbon nanoparticles translocate directly into the circulation in humans? Am J Respir Crit Care Med; 173: 426-31.
58. Nemmar A, Hoet PH, Vanquickenborne B et al. (2002) Passage of inhaled particles into the blood crculation in humans. Circulation; 105: 411-4.
59. Oberdörster G, Elder A, Rinderknecht A. (2009) Nanoparticles and the brain: cause for concern? J Nanosci Nanotechnol; 9: 4996-5007.
60. Oberdörster G, Sharp Z, Atudorei V et al. (2004) Translocation of inhaled ultrafine particles to the brain. Inhal Toxicol; 16: 437-45.
61. O'Hagan DT. (1996) The intestinal uptake of particles and the implications for drug and antigen delivery. J Anat; 189: 477-82.
62. Ostiguy C, Lapointe G, Ménard L et al. (2006) Nanoparticles. Current Knowledge about Occupational Health and Safety Risks and Prevention Measures. Studies and Research Projects/ Report R-470. Montréal, Canada: IRSST. pp. 100.
63. Park CW, Rhee YS, Vogt FG, et al. (2012) Advances in microscopy and complementary imaging techniques to assess the fate of drugs ex vivo in respiratory drug delivery: an invited paper. Adv Drug Deliv Rev; 64:344-56.
64. Phillips JI, Green FY, Davies JC et al. (2010) Pulmonary and systemic toxicity following exposure to nickel nanoparticles. Am J Ind Med; 53: 763-7.
65. Powell JJ, Faria N, Thomas-McKay E et al. (2010) Origin and fate of dietary nanoparticles and microparticles in the gastrointestinal tract. J Autoimmun; 34: J226-33.
66. Rendall RE, Phillips JI, Renton KA. (1994) Death following exposure to fine particulate nickel from a metal arc process. Ann Occup Hyg; 38: 921-30.
67. Riviere JE. (2009) Pharmacokinetics of nanomaterials: an overview of carbon nanotubes, fullerenes and quantum dots. Wiley Interdiscip Rev Nanomed Nanobiotechnol; 1: 26-34.
68. Roller J, Laschke MW, Tschernig T, et al. (2011) How to detect a dwarf: in vivo imaging of nanoparticles in the lung. Nanomedicine; 7: 753-62.
69. Sa LT, Albernaz Mde S, Patricio BF et al. (2012) Biodistribution of nanoparticles: initial considerations. J Pharm Biomed Anal; 70: 602-4.
70. Sarlo K, Blackburn KL, Clark ED et al. (2009) Tissue distribution of 20 nm, 100 nm and 1000 nm fluorescent polystyrene latex nanospheres following acute systemic or acute and repeat airway exposure in the rat. Toxicology; 263: 117-26.
71. Sauvain JJ, Sánchez Sandoval Hohl M, Wild P et al. (2014) Exhaled Breath Condensate as a Matrix for Combustion-Based Nanoparticle Exposure and Health Effect Evaluation. J Aerosol Med Pulm Drug Deliv;27:449-58.
72. Schmid O, Möller W, Semmler-Behnke M et al. (2009) Dosimetry and toxicology of inhaled ultrafine particles. Biomarkers; 14 (Suppl 1): 67-73.
73. Singh R, Pantarotto D, Lacerda L et al. (2006) Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers. Proc Natl Acad Sci U S A; 103: 3357-62.
74. Song Y, Li X, Du X. (2009) Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma. Eur Respir J; 34: 559-67.
75. Song Y, Li X, Wang L et al. (2011) Nanomaterials in humans: identification, characteristics, and potential damage. Toxicol Pathol; 39: 841-9.
76. Tassinari R, Cubadda F, Moracci G et al. (2014) Oral, shortterm exposure to titanium dioxide nanoparticles in Sprague-Dawley rat: focus on reproductive and endocrine systems and spleen. Nanotoxicology; 8: 654-62.
77. Theegarten D, Boukercha S, Philippou S et al. (2010) Submesothelial deposition of carbon nanoparticles after toner exposition: case report. Diagn Pathol; 5: 77.
78. Tiede K, Boxall AB, Tear SP et al. (2008) Detection and characterization of engineered nanoparticles in food and the environment. Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 25: 795-821.
79. Tsutsumi Y, Yoshioka Y. (2011) Quantifying the biodistribution of nanoparticles. Nat Nanotechnol; 6: 755.
80. van der Zande M, Vandebriel RJ, Van Doren E et al. (2012) Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano; 6: 7427-42.
81. Wang T, Hsieh H, Hsieh Y et al. (2012) The in vivo biodistribution and fate of CdSe quantum dots in the murine model: a laser ablation inductively coupled plasma mass spectrometry study. Anal Bioanal Chem; 404: 3025-36.
82. Wallenborn JG, McGee JK, Schladweiler MC et al. (2007) Systemic translocation of particulate matter-associated metals following a single intratracheal instillation in rats. Toxicol Sci; 98: 231-9.
83. Wiebert P, Sanchez-Crespo A, Seitz J et al. (2006) Negligible clearance of ultrafine particles retained in healthy and affected human lungs. Eur Respir J; 28: 286-90.
84. Wu M, Gordon RE, Herbert R et al. (2010) Case report: Lung disease in World Trade Center responders exposed to dust and smoke: carbon nanotubes found in the lungs of World Trade Center patients and dust samples. Environ Health Perspect; 118: 499-504.
85. Wu WT, Liao HY, Chung YT et al. (2014) Effect of nanoparticles exposure on fractional exhaled nitric oxide (FENO) in workers exposed to nanomaterials. Int J Mol Sci; 15: 878-94.
86. Yang W, Peters JI, Williams RO III. (2008) Inhaled nanoparticles - a current review. Int J Pharm; 356: 239-47.
87. Zhu MT, Feng WY, Wang Y et al. (2009) Particokinetics and extrapulmonary translocation of intratracheally instilled ferric oxide nanoparticles in rats and the potential health risk assessment. Toxicol Sci; 107: 342-51.